Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -81.76% is in line with its 5-year average of -78.37%, around the middle of its 5-year range (-118.52%–-54.27%).
5.48% below its 12-month average of -77.52%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -104.20%.
NET PROFIT MARGIN
-81.76%
NET PROFIT MARGIN AVG TTM
-77.52%
NET PROFIT MARGIN AVG 3Y
-67.87%
NET PROFIT MARGIN AVG 5Y
-78.37%
NET PROFIT MARGIN AVG 10Y
-77.09%
NET PROFIT MARGIN AVG 15Y
-87.76%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.48%
CURRENT VS 3Y AVG
-20.46%
CURRENT VS 5Y AVG
-4.32%
CURRENT VS 10Y AVG
-6.06%
CURRENT VS 15Y AVG
+6.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 629 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ClearPoint Neuro, Inc.
Market Cap
$331.54M
Net Profit Margin
-81.76%
TTM Avg
-77.52%
3Y Avg
-67.87%
5Y Avg
-78.37%
Market Cap
$335.22M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$322.98M
Net Profit Margin
-214.74%
TTM Avg
-178.01%
3Y Avg
-157.31%
5Y Avg
-157.31%
Market Cap
$324.38M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$324.51M
Net Profit Margin
-289.44%
TTM Avg
-294.02%
3Y Avg
-409.64%
5Y Avg
-336.94%
Market Cap
$345.41M
Net Profit Margin
0.00%
TTM Avg
-11651.99%
3Y Avg
-6142.69%
5Y Avg
-4693.07%
Market Cap
$350.32M
Net Profit Margin
-96.89%
TTM Avg
-148.47%
3Y Avg
-151.80%
5Y Avg
-119.69%
Market Cap
$350.35M
Net Profit Margin
-1091.82%
TTM Avg
-436.37%
3Y Avg
-220.06%
5Y Avg
-1750.93%
Market Cap
$353.89M
Net Profit Margin
8.59%
TTM Avg
7.90%
3Y Avg
10.47%
5Y Avg
19.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $331.54M | -81.76% | -77.52% | -67.87% | -78.37% |
| Agenus Inc. (AGEN)vs › | $335.22M | 69.34% | -109.76% | -150.31% | -135.75% |
| CapsoVision, Inc. (CV)vs › | $322.98M | -214.74% | -178.01% | -157.31% | -157.31% |
| Cabaletta Bio, Inc. (CABA)vs › | $324.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $324.51M | -289.44% | -294.02% | -409.64% | -336.94% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $345.41M | 0.00% | -11651.99% | -6142.69% | -4693.07% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $350.32M | -96.89% | -148.47% | -151.80% | -119.69% |
| Opus Genetics, Inc. (IRD)vs › | $350.35M | -1091.82% | -436.37% | -220.06% | -1750.93% |
| Embecta Corp. (EMBC)vs › | $353.89M | 8.59% | 7.90% | 10.47% | 19.48% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $354.67M | -5.49% | -11.37% | -410.78% | -2049.25% |
Operating Margin
-65.4%
Net Profit Margin
-81.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -104.20% |
| 2026-03-31 | -78.76% |
| 2025-12-31 | -74.79% |
| 2025-09-30 | -66.48% |
| 2025-06-30 | -63.34% |
| 2025-03-31 | -71.02% |
| 2024-12-31 | -69.31% |
| 2024-09-30 | -61.24% |
| 2024-06-30 | -56.10% |
| 2024-03-31 | -54.27% |
| 2023-12-31 | -67.83% |
| 2023-09-30 | -83.46% |
| 2023-06-30 | -118.52% |
| 2023-03-31 | -103.24% |
| 2022-12-31 | -84.75% |
| 2022-09-30 | -73.61% |
| 2022-06-30 | -82.75% |
| 2022-03-31 | -78.69% |
| 2021-12-31 | -96.89% |
| 2021-09-30 | -87.01% |
| 2021-06-30 | -109.67% |
| 2021-03-31 | -62.98% |
| 2020-12-31 | -42.56% |
| 2020-09-30 | -42.17% |
| 2020-06-30 | -67.03% |
| 2020-03-31 | -65.95% |
| 2019-12-31 | -51.26% |
| 2019-09-30 | -38.36% |
| 2019-06-30 | -59.48% |
| 2019-03-31 | -49.37% |
| 2018-12-31 | -53.50% |
| 2018-09-30 | -79.03% |
| 2018-06-30 | -113.98% |
| 2018-03-31 | -101.08% |
| 2017-12-31 | -123.96% |
| 2017-09-30 | -83.02% |
| 2017-06-30 | -101.44% |
| 2017-03-31 | -82.50% |
| 2016-12-31 | -102.80% |
| 2016-09-30 | -158.58% |
| 2016-06-30 | -161.43% |
| 2016-03-31 | -146.60% |
| 2015-12-31 | -79.28% |
| 2015-09-30 | -19.69% |
| 2015-06-30 | -370.59% |
| 2015-03-31 | -390.46% |
| 2014-12-31 | -199.49% |
| 2014-09-30 | -575.99% |
| 2014-06-30 | -134.00% |
| 2014-03-31 | 319.79% |
| 2013-12-31 | -145.85% |
| 2013-09-30 | -344.47% |
| 2013-06-30 | -240.35% |
| 2013-03-31 | -75.15% |
| 2012-12-31 | -29.97% |
| 2012-09-30 | -94.94% |
| 2012-06-30 | -55.36% |
| 2012-03-31 | -354.53% |
| 2011-12-31 | -159.42% |
| 2011-09-30 | -184.92% |
| 2011-06-30 | -286.25% |
